Changing pattern of the genetic diversities of Plasmodium falciparum merozoite surface protein-1 and merozoite surface protein-2 in Myanmar isolates
Plasmodium falciparum merozoite surface protein-1 (PfMSP-1) and -2 (PfMSP-2) are major blood-stage vaccine candidate antigens. Understanding the genetic diversity of the genes, pfmsp-1 and pfmsp-2, is important f...
[WHO] Homa Bay, Kenya, 13 September 2019 - The World Health Organization (WHO) congratulates the Government of Kenya for launching the world's first malaria vaccine today in Homa Bay County, western Kenya.
[Premium Times] Last week, Nigeria's minister of health and the 36 state health commissioners met at the 62nd National Council of Health Meeting to discuss the state of health care delivery in the country.
[Capital FM] Homa Bay -The World Health Organization (WHO) congratulates the Government of Kenya for launching the world's first malaria vaccine today in Homa Bay County, western Kenya.
Kenya on Friday began adding a malaria vaccine to its routine immunization schedule for babies and toddlers, becoming the third African country to roll out the vaccine for a disease that threatens children across the continent.
[WHO] The World Health Organization (WHO) congratulates the Government of Kenya for launching the world's first malaria vaccine today in Homa Bay County, western Kenya.
Kenya becomes 3rd country to roll out world's 1st malaria vaccine; some 435,000 die per year
Kenya on Friday added the world's first malaria vaccine to the routine immunization schedule for children under two, becoming the third country in Africa to roll out the vaccine for the disease that kills one child globally every two minutes.
More than 300,000 children are expected to receive the vaccine over the next three years.
Novel adjuvant technologies have a key role in the development of next-generation vaccines, due to their capacity to modulate the duration, strength and quality of the immune response. The AS01 adjuvant is used in the malaria vaccine RTS,S/AS01 and in the licensed herpes-zoster vaccine (Shingrix) where the vaccine has proven its ability to generate protective responses with both robust humoral and T-cell responses. For many years, animal models have provided insights into adjuvant mode-of-action (MoA), generally through investigating individual genes or proteins. Furthermore, modeling and simulation techniques can be utili...
It may be possible to eradicate malaria—one of history’s deadliest diseases—from the planet by 2050, according to a coalition of 41 leading scientists, economists and health-policy experts writing in the Lancet. “Malaria is one of the oldest and deadliest diseases of humankind,” says Sir Richard Feachem, one of the report’s authors and co-chair of the Lancet commission on malaria eradication. “If we, humankind, were to take on this challenge and eradicate malaria by 2050, it would be an achievement of historic proportions. There would be nothing quite like it.” Malaria, a mos...